Clonal spread of Klebsiella pneumoniae producing CMY-2 AmpC-type beta-lactamase in surgical intensive care units.
Ko
Wen Chien
WC
Division of Infectious Diseases, Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan. winston3415@gmail.com
Lee
Hsin Chun
HC
Yan
Jing Jou
JJ
Wu
Jiunn Jong
JJ
Chang
Chai Ming
CM
Wu
Chi Jung
CJ
Lee
Nan Yao
NY
Chen
Po Ling
PL
Lee
Ching Chi
CC
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002440:Cefoxitin / Q000627:therapeutic use; D002442:Ceftazidime / Q000627:therapeutic use; D018550:Cephalosporin Resistance; D003422:Critical Care / Q000706:statistics & numerical data; D003428:Cross Infection / Q000453:epidemiology / Q000382:microbiology*; D016521:Electrophoresis, Gel, Pulsed-Field; D005260:Female; D006801:Humans; D007525:Isoelectric Focusing; D007710:Klebsiella Infections / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology*; D007711:Klebsiella pneumoniae / Q000187:drug effects / Q000201:enzymology*; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D010641:Phenotype; D012189:Retrospective Studies; D013624:Taiwan / Q000453:epidemiology; D001618:beta-Lactamases / Q000378:metabolism*
D000900:Anti-Bacterial Agents; D002440:Cefoxitin; D002442:Ceftazidime; C103022:beta-lactamase CMY-2; D001618:beta-Lactamases